WHO ICTRP trial
Low Dose Atomoxetine in Cardiovascular Disease: A Pilot Study
ACTRN12615000376549 · Australian New Zealand Clinical Trials Registry (ANZCTR) · Not Recruiting
Key facts
| Trial ID | ACTRN12615000376549 |
|---|---|
| Public title | Low Dose Atomoxetine in Cardiovascular Disease: A Pilot Study |
| Scientific title | Effect of low dose Atomoxetine on stress/anxiety levels and cardiovascular risk in patients with hypertension, hypercholesterolemia, diabetes or other cardiovascular disease. |
| Primary sponsor | Professor Simon Dimmitt |
| Registry | Australian New Zealand Clinical Trials Registry (ANZCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Countries | Australia |
| Conditions | hypertension;hypercholesterolaemia;diabetes;Stress/anxiety;Overweight/obesity; hypertension hypercholesterolaemia diabetes Stress/anxiety Overweight/obesity;Cardiovascular - Hypertension;Mental Health - Anxiety;Metabolic and Endocrine… |
| Interventions | Oral capsule of Atomoxetine Slow Release 3mg taken once daily for 8 weeks. Compliance will be monitored by drug capsule return. Followed by 6 weeks of the same schedule during which time the field will be randomised with a placebo. |
| Registration date | Apr 23, 2015 |
| Target size | 20 |
| Secondary IDs | nil |
| Registry page | anzctr.org.au |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: